| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/10/2003 | US20030131026 Systems and methods for storing, retrieving, and manipulating data in medical processing devices |
| 07/10/2003 | US20030130827 To generate computationally prescreened secondary libraries |
| 07/10/2003 | US20030130804 Systems and methods for analyzing viscoelastic properties of combinatorial libraries of materials |
| 07/10/2003 | US20030130802 Methods and computer software products for designing nucleic acid arrays |
| 07/10/2003 | US20030130800 Region definition procedure and creation of a repeat sequence file |
| 07/10/2003 | US20030130799 Structure/properties correlation with membrane affinity profile |
| 07/10/2003 | US20030130797 Protein modeling tools |
| 07/10/2003 | US20030130596 Device and method for detecting the coagulation functions of global, especially primary hemostasis |
| 07/10/2003 | US20030130592 Method of monitoring the menstrual cycle and/or pregnancy in a female |
| 07/10/2003 | US20030130569 Micro-invasive method for painless detection of analytes in extracellular space |
| 07/10/2003 | US20030130497 Detection of respiratory viruses |
| 07/10/2003 | US20030130496 Immunoglobulins; cloning, amplifying and encoding by DNA sequences, polymerase chain reaction |
| 07/10/2003 | US20030130495 G-protein coupled receptors, signal transduction pathways |
| 07/10/2003 | US20030130494 Mammalian chemokine reagents |
| 07/10/2003 | US20030130491 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/10/2003 | US20030130490 Genetic engineered protein drugs, such as thrombolytic agents, interferons, interleukins, erythropoietins; extracellular |
| 07/10/2003 | US20030130489 Genetic engineered protein drugs, such as thrombolytic agents, interferons, interleukins, erythropoietins |
| 07/10/2003 | US20030130485 Novel human genes and methods of use thereof |
| 07/10/2003 | US20030130483 Amino acid sequences free of signal peptide, encoded by cDNA; fusion proteins |
| 07/10/2003 | US20030130357 Inhibiting ornithine decarboxylase (involved with production of putrescine) with N(1),N(11)-diethylnorspermine |
| 07/10/2003 | US20030130350 Use of difluoromethylornithine (DFMO) for the treatment of amyotrophic lateral sclerosis |
| 07/10/2003 | US20030130216 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease(cad) for treating cardiac disease |
| 07/10/2003 | US20030130214 Proteins, compositions, diagnostic and therapeutic uses thereof |
| 07/10/2003 | US20030130187 Porcine adenovirus type 3 genome |
| 07/10/2003 | US20030130182 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/10/2003 | US20030130181 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/10/2003 | US20030130180 Utilization of an aminopeptidase inhibitor |
| 07/10/2003 | US20030130167 Binding protein as biosensors |
| 07/10/2003 | US20030130165 Method for treating neurodegenerative disorders |
| 07/10/2003 | US20030129770 Method to improve sensitivity of molecular binding assays using phase-sensitive luminescence detection |
| 07/10/2003 | US20030129769 Detecting a difference in the concentration of a protein in a differnet samples, by bonding to radioactive isotopic, mass spectrometric analysis |
| 07/10/2003 | US20030129767 Sample receiving chamber comprising a valve with intaking and discharging aperatures, a test platform; separation, fluid flow, transferring; detection of drugs, glucose or hormones, antibodies |
| 07/10/2003 | US20030129765 Apparatus and methods for chemiluminescent assays |
| 07/10/2003 | US20030129764 Photoluminescent semiconductor materials |
| 07/10/2003 | US20030129763 Method for measuring stress levels in polymeric compositions |
| 07/10/2003 | US20030129762 Diagnosing carnitine deficiency in patients, monitoring by blood analyzing, mass-spectrometry method |
| 07/10/2003 | US20030129760 Mass intensity profiling system and uses thereof |
| 07/10/2003 | US20030129755 Supported in a two dimensional configuration in a storage receptacle; biological samplings, high storage density, high processing rate |
| 07/10/2003 | US20030129754 Quality control material for reagentless measurement of analytes |
| 07/10/2003 | US20030129752 MEKK/JNKK-contingent (mitogen extracellular signal regulated kinases (MEKK), Jun N-terminal kinase) signal transduction pathway; tumor necrosis factor; interleukins |
| 07/10/2003 | US20030129749 Comprises isogeneic antigen presenting cells |
| 07/10/2003 | US20030129746 Monoclonal antibodies for Hepatitis C virus (HCV) infection |
| 07/10/2003 | US20030129745 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 07/10/2003 | US20030129737 Comprises coaxial probe (microwave fields) and radio frequency power supply on support |
| 07/10/2003 | US20030129726 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 07/10/2003 | US20030129706 Fhm, a novel member of the TNF ligand supergene family |
| 07/10/2003 | US20030129702 DNA encoding galanin GALR2 receptors and uses thereof |
| 07/10/2003 | US20030129698 Involved in homo and heterotrimerization or oligomerization |
| 07/10/2003 | US20030129697 Endothelial and Smooth muscle cell-Derived Neuropilin-like molecule; effective in restenosis after percutaneous transluminal coronany angioplasty and arterial sclerosis |
| 07/10/2003 | US20030129696 Polynucleotides and polypeptides encoding receptors |
| 07/10/2003 | US20030129695 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/10/2003 | US20030129694 Linking a bioactive molecule to a cell expressing certain PRO polypeptides by contacting the cell with a specific PRO polypeptide bound to the molecule |
| 07/10/2003 | US20030129693 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/10/2003 | US20030129692 Linking a bioactive molecule to a cell expressing certain PRO polypeptides by contacting the cell with a specific PRO polypeptide bound to the molecule |
| 07/10/2003 | US20030129691 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/10/2003 | US20030129690 Linking a bioactive molecule to a cell expressing certain PRO polypeptides by contacting the cell with a specific PRO polypeptide bound to the molecule |
| 07/10/2003 | US20030129689 Nucleotide sequence that encodes a PRO polypeptide. |
| 07/10/2003 | US20030129686 Novel nucleic acid and polypeptide molecules |
| 07/10/2003 | US20030129681 Method of analyzing components in biological samples |
| 07/10/2003 | US20030129680 Detecting the presence or absence of Dirofilaria immitis, Borrelia burgdorferi, and Ehrlichia canis |
| 07/10/2003 | US20030129679 Methods and devices for collecting and preparing specimens for detection of mycobacteria and antigens |
| 07/10/2003 | US20030129678 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer |
| 07/10/2003 | US20030129677 Early diagnosis, prognosis and rapid identification of a malignant lesion |
| 07/10/2003 | US20030129676 Methods and reagents for the rapid and efficient isolation of circulating cancer cells |
| 07/10/2003 | US20030129675 Assaying the ability of a compound to block the binding of an alpha 4 integrin to a binding partner thereof |
| 07/10/2003 | US20030129674 Diagnostic method for screening complement regulatory protein levels to predict spontaneous abortion |
| 07/10/2003 | US20030129673 Test apparatus for the detection of pharmacologically active compounds from saliva |
| 07/10/2003 | US20030129670 Using hydrophobic fluorescent ion capable of redistributing from a first face of the membrane to a second face of the membrane in response to changes in the membrane potential |
| 07/10/2003 | US20030129669 Determining the effect of each of a plurality of test agents on cells from a subject, and a method to profile patient cell responses to test agents. |
| 07/10/2003 | US20030129668 Method for quantifying TGF-beta |
| 07/10/2003 | US20030129667 Measurement of the altered expression of a marker protein, which is the prion protein PrP-sen |
| 07/10/2003 | US20030129666 Novel proteome analysis method and devices therefor |
| 07/10/2003 | US20030129665 Performing a cluster designation count with an optical disc and disc drive; assays conducted on cell populations derived from blood, hematological leukemias, lymphomas, bone marrow, and stem cells |
| 07/10/2003 | US20030129664 Novel Assays |
| 07/10/2003 | US20030129663 Methods and compositions for modulating oxidized ldl transport |
| 07/10/2003 | US20030129662 Use of vascular endothelial growth factor (VEGF) |
| 07/10/2003 | US20030129661 Antibody raised against total extractable denatured components of meals from different animal and plant species and its use to detect and quantify materials derived from these species in animal fodder |
| 07/10/2003 | US20030129660 Efficient method for the joint analysis of molecular expression data and biological networks |
| 07/10/2003 | US20030129659 Machine-based method for managing library information, comprising: storing information about associations between members and assay information, and evaluating the stored information to identify a subset of the individual members |
| 07/10/2003 | US20030129658 Novel protease |
| 07/10/2003 | US20030129657 Improving the accuracy by deconvoluting the spectrum if it contains signals of ioins with multiple charges and replacing the measured mass values each by the nearest most probable mass value for the class of biopolymers |
| 07/10/2003 | US20030129656 Producing a computer readable database comprising the three-dimensional molecular structural coordinates of binding pocket of a BNAB protein |
| 07/10/2003 | US20030129655 Nucleic acids encoding GTPase activating proteins |
| 07/10/2003 | US20030129654 Coded particles for multiplexed analysis of biological samples |
| 07/10/2003 | US20030129650 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/10/2003 | US20030129644 Used in gene therapy |
| 07/10/2003 | US20030129643 T1 receptor-like ligand I |
| 07/10/2003 | US20030129642 Novel compositions and methods for inhibiting light-induced inactivation of biological reagents |
| 07/10/2003 | US20030129641 Detecting a nucleic acid specific to the biospecies by hybridizing oligonucleotide synthesized based on a sequence specific to the biospecies in a DNA sequence corresponding to a ribosomal RNA gene or a cytochrome-related gene |
| 07/10/2003 | US20030129640 Target detection method, reagent and method for detecting SNP of DNA nucleotide sequences |
| 07/10/2003 | US20030129634 General screening method for ligand-protein interactions |
| 07/10/2003 | US20030129629 Methods and compositions for the identification, assessment, prevention, and therapy of human cancers |
| 07/10/2003 | US20030129626 Methods, kits and compositions pertaining to the suppression of detectable probe binding to randomly distributed repeat sequences in genomic nucleic acid |
| 07/10/2003 | US20030129622 Biosensor |
| 07/10/2003 | US20030129618 Sensitive and rapid detection of pathogenic organisms and toxins using fluorescent polymeric lipids |
| 07/10/2003 | US20030129617 Calculating a biological characteristic property of a molecule by correlation analysis |
| 07/10/2003 | US20030129609 Assaying for the presence of a genotype characterized by a polymorphism in the NRAMP1 gene. |
| 07/10/2003 | US20030129608 Non-alloying core shell nanoparticles |
| 07/10/2003 | US20030129606 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 07/10/2003 | US20030129597 Inhibiting EG-1 to inhibit angiogenesis and metastasis |